Overexpression of RUNX3 Inhibits Malignant Behaviour of Eca109 Cells in Vitro and Vivo |
Chen, Hua-Xia
(Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University)
Wang, Shuai (Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University) Wang, Zhou (Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University) Zhang, Zhi-Ping (Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University) Shi, Shan-Shan (Department of Obstetrics and Gynecology, Western Provincial Hospital Affiliated to Shandong University) |
1 | Ito K, Lim AC, Salto-Tellez M, et al (2008). RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell, 14, 226-37. DOI ScienceOn |
2 | Chen G, Wang Z, Liu XY, Liu FY (2009). Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? Ann Thorac Surg, 87, 1697-702. DOI ScienceOn |
3 | Dresner SM, Griffin SM (2000). Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg, 87, 1426-33. DOI ScienceOn |
4 | Ito K, Liu Q, Salto-Tellez M, et al (2005). RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res, 65, 7743-50. DOI |
5 | Kim HR, Oh BC, Choi JK, Bae SC (2008). Pim-1 kinase phosphorylates and stabilizes RUNX3 and alters its subcellular localization. J Cell Biochem, 105, 1048-58. DOI ScienceOn |
6 | Lau QC, Raja E, Salto-Tellez M, et al (2006). RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res, 66, 6512-20. DOI ScienceOn |
7 | Li QL, Ito K, Sakakura C, et al (2002). Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell, 109, 113-24. DOI ScienceOn |
8 | Miyazono K, Suzuki H, Imamura T. (2003). Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci, 94, 230-34. DOI ScienceOn |
9 | Nakagawa S, Kanda T, Kosugi S, et al (2004). Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg, 198, 205-11. DOI ScienceOn |
10 | Bangsow C, Rubins N, Glusman G, et al (2001). The RUNX3 gene sequence, structure and regulated expression. Gene, 279, 221-32. DOI ScienceOn |
11 | Soong R, Shah N, Peh B.K, et al (2009). The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome. Br J Cancer, 100, 676-9. DOI ScienceOn |
12 | Torquati A, O'rear L, Longobardi L, et al (2004). RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells. Surgery, 136, 310-6. DOI ScienceOn |
13 | Wang S, Liu H, Akhtar J, Chen HX, Wang Z (2013). Alteration of runt-related transcription factor 3 gene expression and biologic behavior of esophageal carcinoma TE-1 cells after 5-azacytidine intervention. Asian Pac J Cancer Prev, 14, 5427-33. DOI ScienceOn |
14 | Won YW, Lee M, Kim HA, Bull DA, Kim SW (2003). Hypoxiainducible plasmid expressing both miSHP-1 and HO-1 for the treatment of ischemic disease. J Control Release, 11, 22-8. |
15 | Subramaniam MM, Chan JY, Soong R, et al (2009). RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis. Am J Gastroenterol, 104, 426-36. DOI ScienceOn |
16 | Nevadunsky NS, Barbieri JS, Kwong J, et al (2009). RUNX3 protein is overexpressed in human epithelial ovarian cancer. Gynecol Oncol, 112, 325-30. DOI ScienceOn |
17 | Sakakura C, Miyagawa K, Fukuda KI, et al (2007). Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis. Oncogene, 26, 5927-38. DOI ScienceOn |
18 | Subramaniam MM, Chan JY, Soong R, et al (2009). RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression. Breast Cancer Res Treat, 113, 113-21. DOI |
19 | Sugiura H, Ishiguro H, Kuwabara Y, et al (2008). Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep, 19, 713-19. |
20 | Sun ZG, Wang Z, Liu XY, Liu FY (2011). Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy. World J Surg, 35, 70-7. DOI |
21 | Smith E, De Young NJ, Pavey SJ, et al (2008). Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma. Mol Cancer, 7, 75. DOI ScienceOn |
22 | Tonomoto Y, Tachibana M, Dhar D.K, et al (2007). Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis. Oncology, 73, 346-56. DOI ScienceOn |
23 | Hiramatsu T, Osaki M, Ito Y, et al (2005). Expression of RUNX3 protein in human esophageal mucosa and squamous cell carcinoma. Pathobiology, 72, 316-24. DOI ScienceOn |